What is the First-line Empiric Therapy for Candidemia?

Video

Monica Mahoney, PharmD, BCPS-AQ ID, explains the first-line empiric therapy for candidemia.

Monica Mahoney, PharmD, BCPS-AQ ID, clinical pharmacy coordinator of infectious diseases at Beth Israel Deaconess Medical Center, discusses the changes the Infectious Diseases Society of America made in their candidemia guidelines. Now, regardless of immunocompromised status, IDSA recommends echinocandins as the first-line therapy for candidemia. Dr. Mahoney also explains potential reasons why this change was made.

Recent Videos
© 2024 MJH Life Sciences

All rights reserved.